The Company can develop the methods for different oligonucleotide products from the perspectives of product purity, related substances, moisture, elemental impurities, sodium salt, residual solvents, content, microbial limits and bacterial endotoxin, and carry out methodological validation of the developed analytical methods according to customer requirements, so as to make them meet the testing and quality control requirements of oligonucleotide drugs.